The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Zomig 2.5 mg Tablets

Grunenthal Pharma LtdPA2242/004/001

Main Information

Trade NameZomig 2.5 mg Tablets
Active SubstancesZolmitriptan
Dosage FormFilm-coated tablet
Licence HolderGrunenthal Pharma Ltd
Licence NumberPA2242/004/001

Group Information

ATC CodeN02CC Selective serotonin (5HT1) agonists
N02CC03 zolmitriptan


License statusAuthorised
Licence Issued20/02/1998
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back